MedeConnect Healthcare Insight appoints Nicky Richards and Neil Reynolds
October 1, 2009Sales and Marketing appointment, medeconnect, sales and marketing
MedeConnect Healthcare Insight, the market research division of Doctors.net.uk, has announced the appointment of two client services directors: Nicky Richards, …
Marilyn Ewan, account director, Fleishman-Hillard
October 1, 2009Medical Communications Fleishman, appointment, medical communications
Fleishman-Hillard Group has appointed Marilyn Ewan as an account director in its healthcare division.Marilyn brings all-round account handling experience to …
Europe warns pharma about further competition probes
October 1, 2009Sales and Marketing EU, antitrust investigation, reg
The European Commission has warned the industry a new round of antitrust probes will be coming soon, just as the …
Sanofi-Aventis acquires French biotech Fovea
October 1, 2009Sales and Marketing Sanofi, ophth
Sanofi-Aventis is to acquire Fovea Pharmaceuticals, a privately held French company with a focus on diseases of the eye.Fovea has …
New 2-in-1 Valturna outperforms Diovan
October 1, 2009Sales and Marketing Diovan, Novartis, Tekturna, cv, hyp, hypertension
Novartis has gained US approval for a combination of its blockbuster blood pressure drug Diovan and its follow-up product Tekturna/Rasilez.Valturna …
Marketers: get more bang for your buck
October 1, 2009Medical Communications MSI, marketing
Pharma marketing is under increasing pressure to demonstrate how it adds value, especially when it comes to justifying expenditure. Brand …
We’re playing catch up on Twitter, admits Pfizer
September 30, 2009Medical Communications Pfizer, digi
Pfizer has joined other leading pharma companies by launching its own official company Twitter update. The company began using its …
Lilly to cut 5,500 jobs in major restructuring
September 30, 2009Sales and Marketing lilly, restructure
Lilly’s chief executive has unveiled a major restructuring which will see it shed 5,500 jobs, helping to cut costs and …
Europe approves two swine-flu vaccines
September 30, 2009Sales and Marketing EU, GSK, Novartis, h1n1
The European Commission has approved the use of two vaccines for the pandemic H1N1 virus, commonly known as swine flu. …
Sanofi on track to deliver flu vaccine
September 30, 2009Sales and Marketing Sanofi, h1n1
French company Sanofi-Pasteur is on track to deliver its H1N1 flu vaccine over the next two months, chief executive Chris …
GSK faces fresh US delays over Cervarix
September 30, 2009Sales and Marketing Cervarix, GSK, vaccines
GSK faces new delays in the US over the approval of its cervical cancer vaccine Cervarix, after the FDA failed …
24 companies vie for PM Digital Awards
September 29, 2009Medical Communications digi
Marketers and agencies are to get together this month for the first ever UK pharma digital media awards ceremony.The PM …
Expansion plan at Almac prompts recruitment drive
September 29, 2009Manufacturing and Production Almac
Northern Ireland's Almac Group has announced another raft of expansions in its contract research and manufacturing operations, which could boost …
J&J buys stake in vaccines firm Crucell
September 29, 2009Sales and Marketing Crucell, JJ, vaccines
Johnson & Johnson has acquired an 18% stake in Netherlands-based vaccines firm Crucell, and the two companies will work together …
Digital Pharma: From virtual to actual
September 29, 2009Medical Communications digi, digital pharma, hcsmeu
Mental health services have ‘considerable room for improvement’
September 28, 2009NHS, hc
The state of England's mental health services has been lambasted in a report from the Care Quality Commission (CQC). The …
Quality by design pilot extended by FDA
September 28, 2009NHS, hc
The US Food and Drug Administration has extended the deadline for groups wishing to take part in its quality-by-design pilot …
Chop and change for pharma production facilities
September 28, 2009Manufacturing and Production AZ, Teva
Quintiles opens Scottish central lab
September 28, 2009Research and Development Quintiles, Scotland
Quintiles has opened new facilities near Edinburgh, Scotland, that more than double its ability to provide central laboratory services to …
Abbott buys Solvay for $6.6 billion
September 28, 2009Sales and Marketing Abbott, Solvay, cystic fibrosis
Abbott is to buy the pharma division of Belgium-based Solvay for 4.5 billion euros ($6.6 billion) in cash.Solvay declared in …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
